Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume $0.25 +0.02 (+6.38%) As of 07/25/2025 03:35 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Guided Therapeutics Short Interest DataGuided Therapeutics (GTHP) has a short interest of 5,000 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a -24.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 5,913 shares to cover all short positions.Current Short Interest5,000 sharesPrevious Short Interest6,600 sharesChange Vs. Previous Month-24.24%Dollar Volume Sold Short$1.25 thousandShort Interest Ratio0.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares80,284,000 sharesShort Percent of Float0.02%Today's Trading Volume213 sharesAverage Trading Volume5,913 sharesToday's Volume Vs. Average4% Short Selling Guided Therapeutics? Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGTHP Short Interest Over TimeGTHP Days to Cover Over TimeGTHP Percentage of Float Shorted Over Time Guided Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20255,000 shares $1.25 thousand -24.2%0.0%0.4 $0.25 6/15/20256,600 shares $1.25 thousand No Change0.0%0.2 $0.19 5/15/20258,400 shares $756.00 +8,300.0%0.0%0.5 $0.09 4/30/2025100 shares $10.50 -97.9%N/A0 $0.11 4/15/20254,800 shares $432.00 No Change0.0%0.1 $0.09 2/15/202513,800 shares $1.66 thousand +40.8%0.1%0.5 $0.12 1/31/20259,800 shares $1.27 thousand +25.6%N/A0.3 $0.13 1/15/20257,800 shares $1.11 thousand No ChangeN/A0.8 $0.14 12/31/20247,800 shares $1.17 thousand No ChangeN/A0.2 $0.15 11/15/2024400 shares $68.00 -96.7%N/A0 $0.17 Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202412,000 shares $2.40 thousand -2.4%N/A0.2 $0.20 10/15/202412,300 shares $1.72 thousand -6.1%N/A4.7 $0.14 9/30/202413,100 shares $2.29 thousand +36.5%N/A1.4 $0.18 9/15/20249,600 shares $1.82 thousand +146.2%N/A1 $0.19 8/31/20243,900 shares $538.20 +1,200.0%N/A0.3 $0.14 8/15/2024300 shares $35.37 -72.7%N/A0 $0.12 7/31/20241,100 shares $132.00 -38.9%N/A0.1 $0.12 7/15/20241,800 shares $239.28 No ChangeN/A0 $0.13 6/15/20242,000 shares $280.00 -52.4%N/A0 $0.14 5/31/20244,200 shares $420.00 -71.0%N/A0.2 $0.10 5/15/202414,500 shares $1.16 thousand +137.7%N/A0.1 $0.08 4/30/20246,100 shares $664.90 -77.2%N/A0.5 $0.11 4/15/202426,700 shares $2.56 thousand +256.0%N/A0.9 $0.10 3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12 2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14 2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14 1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14 12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15 12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19 11/30/2023700 shares $94.50 -70.8%N/A0 $0.14 11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13 10/31/20236,700 shares $1.01 thousand No ChangeN/A0.2 $0.15 9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14 8/31/202310,600 shares $1.59 thousand -33.8%N/A0.2 $0.15 8/15/202316,000 shares $2.16 thousand -0.6%N/A0.6 $0.14 7/31/202316,100 shares $2.33 thousand +26.8%N/A0.7 $0.15 7/15/202312,700 shares $2.67 thousand +32.3%N/A1.3 $0.21 6/30/20239,600 shares $2.16 thousand +47.7%N/A0.2 $0.23 6/15/20236,500 shares $1.04 thousand -55.5%N/A0 $0.16 5/31/202314,600 shares $2.77 thousand +89.6%N/A1.2 $0.19Critical AI announcement set to ignite AI 2.0 (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 5/15/20237,700 shares $1.31 thousand -56.7%N/A0.1 $0.17 4/30/202317,800 shares $4.27 thousand +17,700.0%N/A0.8 $0.24 4/15/2023100 shares $28.00 -96.9%N/A0 $0.28 3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23 3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29 2/28/2023100 shares $29.00 -95.7%N/A0 $0.29 2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33 1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35 12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30 12/15/202219,500 shares $6.43 thousand -21.4%N/A2.9 $0.33 11/30/202224,800 shares $8.67 thousand +13.2%N/A2.5 $0.35 11/15/202221,900 shares $6.13 thousand +10.6%N/A1 $0.28 10/31/202219,800 shares $5.94 thousand -2.0%N/A0.8 $0.30 10/15/202220,200 shares $9.09 thousand -7.8%N/A3.5 $0.45 9/30/202221,900 shares $11.17 thousand +10.6%N/A2.3 $0.51 9/15/202219,800 shares $10.54 thousand No ChangeN/A2.8 $0.53 8/31/202219,800 shares $9.70 thousand -1.5%N/A6.4 $0.49 8/15/202220,100 shares $11.66 thousand +133.7%N/A2.4 $0.58 7/31/20228,600 shares $4.47 thousand +855.6%N/A1 $0.52 7/15/2022900 shares $512.28 No ChangeN/A0 $0.57 6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48 5/31/20223,800 shares $1.94 thousand +192.3%N/A0.1 $0.51 5/15/20221,300 shares $715.00 No ChangeN/A0.1 $0.55 3/31/2022300 shares $195.00 -83.3%N/A0 $0.65 3/15/20221,800 shares $918.00 +1,700.0%N/A0.2 $0.51 2/28/2022100 shares $52.50 No ChangeN/A0 $0.53 2/15/2022100 shares $62.50 No ChangeN/A0 $0.63 1/31/2022100 shares $60.00 -75.0%N/A0 $0.60 1/15/2022400 shares $240.00 +300.0%N/A0 $0.60 12/31/2021100 shares $58.02 No ChangeN/A0 $0.58 12/15/2021100 shares $64.94 No ChangeN/A0 $0.65 11/30/2021100 shares $67.50 -50.0%N/A0 $0.68 11/15/2021200 shares $114.02 +100.0%N/A0 $0.57 10/29/2021100 shares $57.00 No ChangeN/A0 $0.57 10/15/2021100 shares $54.00 No ChangeN/A0 $0.54 9/30/2021100 shares $55.99 -98.2%N/A0 $0.56 9/15/20215,400 shares $3.35 thousand +17.4%N/A0.4 $0.62 8/31/20214,600 shares $2.53 thousand +475.0%N/A0.2 $0.55 8/13/2021800 shares $410.16 +700.0%N/A0 $0.51 7/30/2021100 shares $59.00 -95.7%N/A0 $0.59 7/15/20212,300 shares $1.43 thousand +35.3%N/A0.3 $0.62 6/30/20211,700 shares $1.07 thousand +240.0%N/A0.2 $0.63 6/15/2021500 shares $331.30 +400.0%N/A0 $0.66 5/28/2021100 shares $59.25 No ChangeN/A0 $0.59 5/14/2021100 shares $64.00 -75.0%N/A0 $0.64 4/30/2021400 shares $276.04 No ChangeN/A0 $0.69 3/15/2021100 shares $75.00 -92.3%N/A0 $0.75 2/26/20211,300 shares $1.16 thousand -81.4%N/A0 $0.89 2/12/20217,000 shares $3.50 thousand -41.2%N/A0.3 $0.50 1/29/202111,900 shares $5.00 thousand +5,850.0%N/A0.3 $0.42Critical AI announcement set to ignite AI 2.0 (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 1/15/202113,800 shares $5.53 thousand +294.3%N/A0.2 $0.40 12/31/20206,600 shares $2.17 thousand -52.2%N/A0.5 $0.33 12/15/202013,800 shares $2.50 thousand +294.3%N/A0.2 $0.18 11/30/20203,500 shares $665.00 -78.7%N/A0.1 $0.19 11/15/202016,400 shares $4.61 thousand +1,540.0%N/A0.6 $0.28 10/30/20201,000 shares $363.00 +11.1%N/A0.1 $0.36 10/15/2020900 shares $279.18 +125.0%N/A0.2 $0.31 9/30/2020400 shares $148.00 -91.8%N/A0.1 $0.37 9/15/20204,900 shares $1.81 thousand -70.8%N/A0.5 $0.37 GTHP Short Interest - Frequently Asked Questions What is Guided Therapeutics' current short interest? Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 5,000 shares of GTHP short. 0.02% of Guided Therapeutics' shares are currently sold short. Learn More on Guided Therapeutics' current short interest. What is a good short interest percentage for Guided Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Guided Therapeutics' floating shares are currently sold short. Is Guided Therapeutics' short interest increasing or decreasing? Guided Therapeutics saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 5,000 shares, a decrease of 24.2% from the previous total of 6,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guided Therapeutics' short interest compare to its competitors? 0.02% of Guided Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Guided Therapeutics: Hyperfine, Inc. (5.17%), TELA Bio, Inc. (1.34%), Carmell Co. (0.60%), Myomo, Inc. (4.96%), InspireMD, Inc. (1.75%), Sensus Healthcare, Inc. (6.33%), Zynex Inc. (45.18%), Spectral AI, Inc. (4.90%), Advanced Medical Isotope Corporation (0.00%), Cytosorbents Corporation (2.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Guided Therapeutics stock? Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. GTHP shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guided Therapeutics? A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further. How often is Guided Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Hyperfine Short Squeeze TELA Bio Short Squeeze Carmell Short Squeeze Myomo Short Squeeze InspireMD Short Squeeze Sensus Healthcare Short Squeeze Zynex Short Squeeze Spectral AI Short Squeeze Advanced Medical Isotope Short Squeeze Cytosorbents Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GTHP) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
